Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Eye irritation in vitro: not irritant

Skin irritation in vitro: not irritant

Key value for chemical safety assessment

Skin irritation / corrosion

Link to relevant study records
Reference
Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Qualifier:
according to guideline
Guideline:
EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
GLP compliance:
yes (incl. QA statement)
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: 30869
- Expiration date of the lot/batch: 2019-01-31

STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature
Test system:
human skin model
Source species:
human
Cell type:
non-transformed keratinocytes
Vehicle:
unchanged (no vehicle)
Details on test system:
Skin model: API-200
Supplier: MatTek In Vitro Life Science Laboratories, Bratislava, Slovakia
Control samples:
yes, concurrent negative control
yes, concurrent positive control
other: MTT reduction control
Amount/concentration applied:
30µl
Duration of treatment / exposure:
1h total (25min at room temperature and 35 minutes in the incubator)
Duration of post-treatment incubation (if applicable):
The tissues were incubated in the incubator at 37°C for 24 ± 2 hours. After 24 ± 2 hours, the tissues were transferred into new 6-well plates pre-filled with 0.9 mL fresh medium and placed into the incubator for an additional 18 ± 2-hour post-incubation period.
Number of replicates:
3
Irritation / corrosion parameter:
% tissue viability
Value:
107
Negative controls validity:
valid
Positive controls validity:
valid
Other effects / acceptance of results:
The substance is considered not to require classification as a skin irritant, if the mean tissue viability exceeds 50%.
Interpretation of results:
GHS criteria not met
Conclusions:
Based on the results observed and by applying the evaluation criteria, it was concluded that Reaction mass of Hexanedioic acid, 1-cyclohexyl 6-(2-ethylhexyl) ester, Hexanedioic acid, 1,6-dicyclohexyl ester and Hexanedioic acid, 1,6-bis(2-ethylhexyl) ester does not show a skin irritation potential in the EpiDermTM in vitro skin irritation test under the test conditions chosen.
Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Eye irritation

Link to relevant study records
Reference
Endpoint:
eye irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
GLP compliance:
yes (incl. QA statement)
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: 30869
- Expiration date of the lot/batch: 2019-01-31

STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature
Species:
human
Details on test animals or tissues and environmental conditions:
EpiOcular OCL-200 kit from MatTek In Vitro Life Sciences, Bratislave, Slovakia
Reconstructed cornea: three-dimensional non-keratinized tissue construct composed of normal human-derived epidermal keratinocytes
Vehicle:
unchanged (no vehicle)
Controls:
yes, concurrent positive control
yes, concurrent negative control
other: MTT reduction control
Amount / concentration applied:
50µl
Duration of treatment / exposure:
30min
Duration of post- treatment incubation (in vitro):
2h
Number of animals or in vitro replicates:
2
Irritation parameter:
other: tissue viability
Value:
103
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation

Test substance

 

tissue 1

tissue 2

mean

inter-tissue variability [%]

NC

mean OD570

2.205

2.233

2.219

 

viability

[% of NC]

99.4

100.6

100.0

1.2

18/0104-1

mean OD570

2.308

2.242

2.275

 

viability

[% of NC]

104.0

101.0

102.5

3.0

PC

mean OD570

0.810

0.671

0.741

 

viability

[% of NC]

36.5

30.2

33.4

6.3

Interpretation of results:
GHS criteria not met
Conclusions:
Based on the results observed and by applying the evaluation criteria, it was concluded that Reaction mass of Hexanedioic acid, 1-cyclohexyl 6-(2-ethylhexyl) ester, Hexanedioic acid, 1,6-dicyclohexyl ester and Hexanedioic acid, 1,6-bis(2-ethylhexyl) ester does not show an eye irritation potential in the EpiOcular™ in vitro eye irritation test under the test conditions chosen.
Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Respiratory irritation

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

The potential to cause dermal irritation was assessed by a single topical application of 30 μL of the undiluted test substance to a reconstructed three-dimensional human epidermis model (EpiDerm™). The irritation test was performed with three EpiDerm™ tissues, which were incubated with the test substance for 1 hour followed by a 24 -hours post-incubation period. Tissue destruction was determined by measuring the metabolic activity of the tissue after exposure/post-incubation using a colorimetric test (MTT) to measure relative viability. The mean viability of the test-substance treated tissues was 107%. Based on the observed results, it was concluded, that the test substance does not show a skin irritation potential in the EpiDerm™ in vitro skin irritation and corrosion test strategy under the test conditions chosen. No further test for skin corrosion is required.

The potential to cause ocular irritation was assessed by a single topical application of 50 µL of the undiluted test substance to a reconstructed three-dimensional human cornea model (EpiOcular™). Two EpiOcular™ tissues were incubated with the test substance for 30 minutes followed by a 2-hours post-incubation period. Tissue destruction was determined by measuring the metabolic activity of the tissue after exposure/post-incubation using a colorimetric test (MTT). The mean viability of the test-substance treated tissues was 103%. Consequently, the test substance does not show an eye irritation potential in the in vitro eye irritation test strategy under the test conditions chosen. No further in vitro assays (BCOP) were required, since for non-irritant substances the differentiation between irritant and corrosive properties is unnecessary.

Justification for classification or non-classification

Since no indication of skin or eye irriation was detected in the corresponding in vitro assays, no classification according to Regulation (EC) No 1272/2008 (CLP) is required.